Clinical Trials Browser

OTHER × Urologic Neoplasms × Dermatologic × Clear all

Bone Neoplasms, Melanoma, Osteosarcoma, Urologic Neoplasms

NCT03420963 2026-03-20

Donor Natural Killer Cells, Cyclophosphamide, and Etoposide in Treating Children and Young Adults With Relapsed or Refractory Solid Tumors

DermatologicGenitourinaryHead & NeckOther solid neoplasmSarcomaThoracic

Mesothelioma, Malignant, Bone Neoplasms, Endocrine Gland Neoplasms, Melanoma, Mouth Neoplasms, Pharyngeal Neoplasms, Sarcoma, Skin Neoplasms, Thyroid Neoplasms, Urologic Neoplasms

NCT02836795 2025-06-08

Safety and Tolerability of Recombinant Humanized Anti-PD-1 Monoclonal Antibody Toripalimab for Patients With Advanced Solid Tumors

Phase 1 Completed

35 enrolled

DermatologicGenitourinary

Melanoma, Urologic Neoplasms

NCT03245788 2019-04-08

Effectiveness of Lay Navigators in Meeting Cancer Patients' Non-Clinical Needs: A Pilot Study

Phase NA Completed

1,053 enrolled

BreastDermatologicGastrointestinalGenitourinaryHead & NeckLymphoidSarcoma

Breast Neoplasms, Gastrointestinal Neoplasms, Head and Neck Neoplasms, Lymphoma, Sarcoma, Skin Neoplasms, Urologic Neoplasms

Clinical Trials

Study of Aerosol Gemcitabine in Patients With Solid Tumors and Pulmonary Metastases

Donor Natural Killer Cells, Cyclophosphamide, and Etoposide in Treating Children and Young Adults With Relapsed or Refractory Solid Tumors

Safety and Tolerability of Recombinant Humanized Anti-PD-1 Monoclonal Antibody Toripalimab for Patients With Advanced Solid Tumors

Effectiveness of Lay Navigators in Meeting Cancer Patients' Non-Clinical Needs: A Pilot Study